英文名稱 Anti-ADAM17/FITC

中文名稱 FITC標(biāo)記的腫瘤壞死因子α轉(zhuǎn)換酶

規(guī)格:100ul

說明書 100ul  

研究領(lǐng)域腫瘤  免疫學(xué)  神經(jīng)生物學(xué)  信號(hào)轉(zhuǎn)導(dǎo)  轉(zhuǎn)錄調(diào)節(jié)因子  

抗體來源Rabbit

克隆類型Polyclonal

交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Rabbit,

產(chǎn)品應(yīng)用Flow-Cyt=1:50-200 IF=1:50-200  

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

分子量68/93kDa

細(xì)胞定位細(xì)胞膜

性    狀Lyophilized or Liquid

濃    度1mg/ml

免疫原KLH conjugated synthetic peptide derived from human ADAM17

亞    型IgG

純化方法affinity purified by Protein A

儲(chǔ)存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

保存條件Store at -20 °C for one year.

別　名　 A disintegrin and metalloproteinase domain 17; ADAM 17; ADAM metallopeptidase domain 17; ADAM17 protein; CD 156b; CD156b; CD156b antigen; CSVP; MGC71942; Snake venom like protease; TACE; TNF alpha convertase; TNF alpha converting enzyme; Tumor Necrosis Factor Alpha Converting Enzyme; A disintegrin and metalloproteinase domain 17 (tumor necrosis factor, alpha, converting enzyme); ADA17_HUMAN.